Related Experiment Video

Updated: Aug 18, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Effect of a histone deacetylase inhibitor on human cardiac mass

Yukitaka Shizukuda, Richard L Piekarz, Susan E Bates

    Cardiovascular Drugs and Therapy
    |May 11, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
    08:00

    Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

    Published on: July 10, 2019

    Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue
    09:43

    Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

    Published on: November 30, 2018

    Related Experiment Videos

    Last Updated: Aug 18, 2026

    Assays for Validating Histone Acetyltransferase Inhibitors
    09:11

    Assays for Validating Histone Acetyltransferase Inhibitors

    Published on: August 6, 2020

    Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
    08:00

    Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

    Published on: July 10, 2019

    Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue
    09:43

    Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

    Published on: November 30, 2018

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Male breast cancer: from extrapolated practice to evidence-based care.

    The oncologist·2026

    Impact of Beta Blockers, Statins, and Cholinergic Agents on Clinical Outcomes in Pancreatic Cancer: A Retrospective VA Cohort Study.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

    Köhlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy.

    Cell reports. Medicine·2026

    Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma.

    The oncologist·2026

    International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma.

    Cancers·2025

    Precision Use of Ivabradine in Contemporary HFrEF: From Heart Rate Reduction to Physiological Optimization.

    Cardiovascular drugs and therapy·2026

    Baxdrostat in Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.

    Cardiovascular drugs and therapy·2026

    Combined Prognostic Value of Triglyceride-Glucose Index and Bilirubin in Drug-Eluting Stent Restenosis: From Clinical Risk Stratification to Exploratory Vascular-Cell Findings.

    Cardiovascular drugs and therapy·2026

    Allopurinol for Marfan Aortopathy: Pharmacogenomic Safety and Sex-Stratified Trial Design Warrant Consideration.

    Cardiovascular drugs and therapy·2026

    METTL3 Confers Ischemia/Reperfusion-Caused Myocardial Injury by Triggering Ferroptosis via Regulating the lncRNA SNHG14/miR-195a-5p/ACSL4 Axis.

    Cardiovascular drugs and therapy·2026

    PDK4-Associated Metabolic Reprogramming Contributes to Lactate Accumulation and Parthanatos-Related Changes in Septic Cardiomyocytes.

    Cardiovascular drugs and therapy·2026

    Giant cardiac hemangioma: case report and literature review.

    European heart journal. Case reports·2026

    Integrated microarray-based and single-cell transcriptomic analyses reveal cell adhesion-related fibrotic remodeling signatures in heart failure.

    Frontiers in molecular biosciences·2026

    Development and validation of a machine learning model for predicting coronary artery disease risk: a retrospective study.

    Frontiers in cardiovascular medicine·2026

    Metabolic syndrome score and cardiovascular disease risk in adults with cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study.

    Metabolism open·2026

    EHA Guidelines on the management of children and adults with hemoglobin SC disease.

    HemaSphere·2026

    A diagnostic and classification model integrating cTnI, CK-MB, MYO and NT-proBNP for cardiovascular diseases.

    Experimental and therapeutic medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us